A SAGE Open Access journal | Publishing high-quality articles in infectious disease | Editor-in-Chief @andhen25 | IF 3.8
SAGE Publishing, London
Joined February 2020
- Tweets1.5K
- Following1K
- Followers1K
- Likes1.4K
Therapeutic Advances in Infectious Disease retweeted
Today is world AIDS day
We made tremendous progress over the last 40 years or so in diagnosis, treatment and prevention of HIV.
But the one thing I wish we had by now?
An effective vaccine
Therapeutic Advances in Infectious Disease retweeted
1 de diciembre/ December 1
#WorldAIDSDay #DiaMundialDelSIDA
Today we have the science and technology to provide the best medications to all those who need to prevent, diagnose and treat HIV.
Therapeutic Advances in Infectious Disease retweeted
Thanks @BritishHIVAssoc
Our chair @ProfYGilleece speaks to @cla_cor about her presentation yesterday on violence against women in Latin America and how this impacts on the HIV response #hivglasgow2024
Therapeutic Advances in Infectious Disease retweeted
Inevitably Clade 1 monkeypox has arrived in the UK.
I remain to be convinced it will turn out to be fundamentally different from the other clades we have seen here, but caution until we know more seems sensible
bbc.co.uk/news/articles/ce3y…
Therapeutic Advances in Infectious Disease retweeted
Current practice of #screening and antimicrobial #prophylaxis to prevent #Gram_negative bacterial infection in high-risk #haematology patients: results from a pan-#European survey
journals.sagepub.com/doi/10.…
@JannikStemler @CornelyOliver @elenicelli
🧵
Therapeutic Advances in Infectious Disease retweeted
Delighted to be given the chance to bring trials of the latest treatments for serious fungal infection to our patients @UCLHresearch
Did you know fungal infection kills nearly 4 MILLION people each year?
Time to tackle it..glad to do my bit
@UCLHresearch
.@DrNeilStone is bringing new trials of novel antifungal drugs to patients at @uclh, which has one of the largest cohorts in Europe for serious fungal infection.
We caught up with him to find out more about his work:
uclhospitals.brc.nihr.ac.uk/…
#research
Therapeutic Advances in Infectious Disease retweeted
STIs in Latin America by Dr Alexis Holguin, current head of ID Peruvian Society. 3.36M new syphilis cases in 2022 in the Americas!
Therapeutic Advances in Infectious Disease retweeted
So grateful to @blandman19 and @stenotrophonina for moderating our @IDWeekmtg session. It was an absolute honor to share the stage with @RachelFoster86—such a surreal and unforgettable experience!
Incredible session on beta-lactams. Huge thanks to @DBChastain @stenotrophonina @RachelFoster86 for a fantastic @IDWeekmtg session! #IDWeek2024
Therapeutic Advances in Infectious Disease retweeted
En #idweek , la conferencia mas grande de enfermedades infecciosas (idweek.org/) presentamos los resultados de varias colaboraciones entre instituciones de Colombia de investigaciones en #Mpox , #neumonia y en #virusrespiratorios
Therapeutic Advances in Infectious Disease retweeted
A huge shoutout to the talented @ferraz_md for her inspiring poster and research on candidemia mortality differences by species at @IDWeekmtg 🌟
Your work is crucial in advancing our understanding and treatment of this serious infection. Bravo! 👏🦠
@CUDivofID @CUAnschutz
Therapeutic Advances in Infectious Disease retweeted
Good board review on Candida treatment. #IDWeek2024
Therapeutic Advances in Infectious Disease retweeted
#IDweek2024 Day 4 session on optimal duration of Abx in certain clinical conditions like empyema, UTI in Tx patients, candidasis.
1. Empyema- did you know about "RAPID" score.
Newer Data available suggests shorter duration maybe acceptable for low RAPID score patients
Therapeutic Advances in Infectious Disease retweeted
Live at #IDWeek2024 @bryan_p_white discussing duration of antimicrobial therapy in empyema @OUHealth @OURxResidency @SIDPharm @IDWeekmtg
Therapeutic Advances in Infectious Disease retweeted
News from IDWeek2024, promising new leprosy treatment option (less
Side effects): 3-drug therapy only once a month for 12-24 months. This makes more sense. Credits to Dr Carlos-Franco Paredes. #IDWeek2024
Therapeutic Advances in Infectious Disease retweeted
From Speit Oriente it is an honor to share these days at @IDWeekmtg with outstanding national and international infectious disease professionals. @IDWeekmtg
@SPEIT_oficial @CasapiaMartin @AlexisHolguinR1 @LAPAHSTropical @SelvaAmazonica @andhen25 #IDWeek2024
Therapeutic Advances in Infectious Disease retweeted
Great meeting with Peruvian team at IDWeek2024. Collaboration is key to success in clinical translational research (Emerging Tropical Diseases/Immunology/Global Health/Climate change). @IDWeekmtg
@SPEIT_oficial @CasapiaMartin @AlexisHolguinR1 @LAPAHSTropical #IDWeek2024
Therapeutic Advances in Infectious Disease retweeted
Killer presentations from @SamPanPharmD & @njrhodes_rx on implementation of Beta-lactam TDM & PK estimate models to promote optimal, individualized patient care! 💉
Repping @MidwesternUniv @mwupce @mwupharmacy @NM_IDSteward @SIDPharm well at @IDWeekmtg #IDWeek2024
Therapeutic Advances in Infectious Disease retweeted
Big congrats to Dr. Samantha Kaplan on her insightful poster presentation on leprosy @IDWeekmtg 🌟 Your work is shedding light on a crucial area of infectious disease. Kudos! 👏🦠 #Leprosy #GlobalHealth
@CUDivofID @LuisAMarcosID
Therapeutic Advances in Infectious Disease retweeted
#IDweek2024 Day2, session 2
With rising rates of MDROs like FQR, ESBL, and CRE in alloSCT patients, how should we rethink prophylaxis strategies? Seems like more questions than answers! – at Los Angeles, CA
